Acelrx pharmaceuticals announces reverse stock split

Hayward, calif. , oct. 25, 2022 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), (acelrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it has filed a certificate of amendment to its certificate of incorporation to effect a reverse stock split of its common stock at a ratio of 1-for-20.
ACRX Ratings Summary
ACRX Quant Ranking